Pfizer Stock News

Mosaic Family Wealth LLC increased its position in shares of Pfizer Inc. (NYSE:PFE) by 19.7% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,997 shares of the biopharmaceutical companys stock after purchasing an additional 5,425 shares during the quarter. Mosaic Family Wealth []

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and Arena Pharmaceuticals, Inc. (ARNA) have entered into a definitive agreement under which Pfizer will acquire Arena. Pfizer will acquire all the outst…

Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Clinical Nutrition Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering.

The United States delivered an additional 49,140 doses of Pfizer COVID-19 vaccines to the people of the Kyrgyz Republic as part of continued pandemic assistance. The U.S. Embassy in the Kyrgyz Republic reported.

Pfizer Buys Pharma Rival Arena In All-Cash Deal Worth $6.7 Billion Shares of Arena Pharmaceuticals have doubled in price in premarket trading after Pfizer announced that it had struck a deal to acquire its smaller rival for $100/share in a deal that values the San Deigo-based Arena at $6.7 billion. Pfizer believes it can finance the deal with cash on hand, and thanks to covid, it sure can. Fattened up with its vaccine profits, Pfizer is clearly seizing the opportunity to put some of that money to work by diversifying and paying growth. Investors in both companies should keep in mind that, as part of the deal, warrants will immediately cease to be outstanding and instead will be converted into the right to receive an amount in cash equal to the product of the excess, if any, of the Merger Consideration over the per-share exercise price of such of the options, multiplied by the number of shares then subject to such Company Option. In the press release, Pfizer''s Mike Gladstone said buying Arena would complement Pfizer''s expertise in immunology, specifically allowing it to better serve patients with immuno-inflammatory diseases. "The proposed acquisition of Arena complements our capabilities and expertise in Inflammation and Immunology, a Pfizer innovation engine developing potential therapies for patients with debilitating immuno-inflammatory diseases with a need for more effective treatment options," said Pfizer''s Mike Gladstone. "Utilizing Pfizer''s leading research and global development capabilities, we plan to accelerate the clinical development of etrasimod for patients with immuno-inflammatory diseases." Read the press release below: Pfizer and Arena Pharmaceuticals, Inc.(Nasdaq: ARNA) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Arena, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases.

A new UK study suggests two doses of the Pfizer and AstraZeneca Covid-19 vaccines induce lower levels of antibodies against Omicron.

Late on Friday, December 10th, Swiss medicines agency Swissmedic approved Covid vaccinations for children aged between 5 and 11. Previously, vaccination was only available for children aged 12 and up. Which vaccine will be administered? The Pfizer/Biontech vaccine has been approved for children in that age group. Only the Pfizer/Biontech, Moderna and the Johnson and []

A Penicillin is a class of antibiotics used in the action of bacterial infections. Penicillin G injection is used to luxury and prevent certain infections produced by bacteria. Penicillin G injection is in a class of medicines called penicillin. It

BEGINNING today, Jamaica will offer a booster shot to all those 18 years and older who have received a single dose of the Johnson & Johnson vaccine. The booster can be given with the Johnson & Johnson vaccine two to six months after the administration of the primary vaccination, or with the Pfizer vaccine six months after the primary vaccination, the Ministry of Health reported. Also starting today, adults 60 years and older and health-care workers will be given a booster dose of the other COVID-19 vaccines. This development comes in the wake of the ministry''s finalisation of its evaluation and benefit analysis of administering an additional dose of the authorised COVID-19 vaccines to key members of the population. The ministry recommends that a booster dose of the Pfizer vaccine be offered six months or more after the completion of the initial doses that may have consisted of either mRNA (Pfizer) or viral vector vaccine (AstraZeneca and Johnson & Johnson). The move is in line with a Cabinet decision for boosters to be given to key populations at increased risk of severe illness from COVID-19, increased risk of waning and/or lower protection, and who could pose increased risk of transmission to vulnerable populations.

Laboratory research has suggested that the Omicron variant can partially escape antibody immunity induced by the Pfizer-BioNTech COVID-19 vaccine. The research, led by Prof. Alex Sigal from the Africa Health Research Institute in South Africa, has been submitted to medRxiv, a preprint server for health sciences. The research confirms predictions that a large number of [] The post Omicron variant can partially escape Pfizer vaccine-induced immunity appeared first on . .

Two dose COVID-19 vaccines developed by Pfizer/BioNTech and AstraZeneca induce a lower amount of antibodies against the Omicron coronavirus strain compared to previous variants, according to an Oxford

"Because of the new version of Omicron, a third dose of RNA vaccine must be given because it really protects. The first two doses of AstraZeneca protect only 20%. However, if a booster dose is given to two previous Pfizer ones, the protection against Omicron is equalized to the one against the Delta variant - 85% it is certain that you will not get sick or if it happens, it will be easier to deal with". This was explained by Prof. Todor Kantardjiev, vaccination consultant of the Sofia Municipality, on the air of Nova TV. He stressed that Omicron is more contagious, but it is milder. Vaccines are slightly weaker against it, and those who have already suffered from COVID-19 can become infected again. The professor predicts that the death rate may rise due to unprovided medical care. According to him, the new cases of coronavirus in our country are decreasing quite slowly, because 10 patients infect 9 people. " We cannot expect a sharp decline in cases. There are many people in intensive care units and there are many dead ," he said.

This article was originally published on TipRanks.com Pharmaceutical and biotechnology company Pfizer, Inc. The post Pfizer Rewards Shareholders With 2.6% Dividend Hike appeared first on Smarter Analyst .

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and Sangamo Therapeutics Inc. (SGMO) announced updated phase 1/2 results showing sustained bleeding control in highest dose cohort through two years fol